This inventor holds 19 USPTO granted patents, primarily in Protein Engineering. Top assignees: Bio Polymers Pty. Ltd., Hexima Limited, The University of Melbourne. Active years: 1990-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 1990-2008
Areas of Expertise:
Title: Innovator Spotlight: Adrienne Elizabeth Clarke
Introduction: Adrienne Elizabeth Clarke is a prolific inventor based in Parkville, AU, known for his impressive portfolio of 19 patents. His groundbreaking work in the field of proteinase inhibitors has garnered international recognition.
Latest Patents: Clarke's most recent patents include a Proteinase inhibitor, precursor thereof, and genetic sequences encoding the same. This innovation focuses on nucleic acid molecules comprising sequences that encode a Type II serine proteinase inhibitor precursor from a plant. These precursors contain multiple monomers with specific sites for chymotrypsin and trypsin. Additionally, he has developed Isolated monomers of a Type II serine proteinase inhibitor.
Career Highlights: Clarke has made significant contributions to the field through his work with companies such as Bio Polymers Pty. Ltd. and Hexima Limited. His expertise and dedication have paved the way for advancements in the understanding and application of proteinase inhibitors in various industries.
Collaborations: Throughout his career, Clarke has collaborated with esteemed professionals such as Marilyn Anne Anderson and Angela Hilary Atkinson. Together, they have synergized their knowledge and skills to drive innovation and achieve remarkable results in their respective fields.
Conclusion: Adrienne Elizabeth Clarke's relentless pursuit of innovation and his remarkable contributions to the field of proteinase inhibitors have solidified his position as a leading inventor. His patents and collaborative efforts continue to inspire and shape the future of biotechnology and genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
